Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Megestrol
  • Quality of Life

abstract

  • Unless additional follow-up data demonstrate a survival advantage at higher doses, the 160-mg/d dose is optimal, achieving maximal treatment effect with the fewest side effects and better quality of life.

publication date

  • December 1993

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 8229122

Additional Document Info

start page

  • 2081

end page

  • 9

volume

  • 11

number

  • 11